Multiple biological activities for two peptides derived from the nerve growth factor precursor

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• ProNGF undergoes proteolytic cleavage, yielding neurotrophic factors like NGF and novel peptides LIP1 and LIP2.
• LIP1 and LIP2 have been identified in rat intestine and shown to activate Trk receptors.
• The biological functions of LIP1 and LIP2 remain largely unexplored.

Purpose of the Study:

• To investigate the novel biological properties and functions of LIP1 and LIP2 peptides.
• To explore the potential roles of LIP1 and LIP2 in cell proliferation, neuroprotection, and microglial cell signaling.

Main Methods:

• Cell culture experiments using MCF-7 cells and primary neuronal cultures.
• In vivo studies involving excitotoxic lesion induction in developing mouse brains.
• Analysis of peptide interactions with microglial cells and downstream signaling pathways (e.g., Akt phosphorylation).

Main Results:

• LIP1 and LIP2 exhibit anti-proliferative effects against estrogen and IGF-induced mitogenesis in MCF-7 cells.
• These peptides provide protection against excitotoxicity in vivo and NMDA-induced cell death in vitro.
• LIP1 and LIP2 bind to microglial cells, inducing Akt phosphorylation.

Conclusions:

• LIP1 and LIP2 possess significant anti-proliferative and neuroprotective activities.
• These peptides modulate microglial cell signaling pathways.
• The findings suggest a critical role for LIP1 and LIP2 in promoting cell survival.